EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Promoter-targeted small RNA duplexes increase MBNL1 transcription and mitigate myotonic dystrophy-associated spliceopathy

Nikola Musiała-Kierklo iD, Patrycja Plewka iD, Adam Jasiok iD, Ewa Stępniak-Konieczna iD

Nucleic Acids Research · 11.08.2025 · 53 (15)

DOI: 10.1093/nar/gkaf756 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 20.08.2025. Verfasst von Nikola Musiała-Kierklo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of RNA Biology, Department of Biochemistry and Biotechnology, Poznan University of Life Sciences, Dojazd 11, 60-632 Poznan, Poland. Hauptthemen laut MEDLINE: Myotonic Dystrophy, RNA-Binding Proteins, Promoter Regions, Genetic, Alternative Splicing. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Functional depletion of Muscleblind-like (MBNL) proteins is a key trigger of myotonic dystrophy (DM)-associated alternative splicing (AltS) defects. To overcome MBNL insufficiency in DM cell models, we harnessed a conserved endogenous mechanism of RNA activation (RNAa) via rationally designed small activating RNA (saRNA) targeted to the most active promoter of MBNL1 gene. We report on two lead saRNA duplexes that stimulated MBNL1 transcription via an on-site mechanism that involves AGO2-mediated loading of the antisense strand onto target sequence, followed by recruitment of RNAPII and auxiliary RNAa pathway components. We demonstrate that neither the antisense lncRNA MBNL1-AS1 overlapping MBNL1 promoter nor promoter-associated cryptic RNAs are mechanistically involved in saRNA-induced MBNL1 gene activation. Our data highlight putative transcription factors whose binding recruitment via identified saRNAs may affect MBNL1 expression. Most importantly, we show that RNAa-based approach upregulates MBNL1 protein content in distinct DM cell models and corrects the AltS of multiple MBNL1-regulated biomarker exons, underscoring the feasibility of adapting saRNA into novel therapeutic designs. This is the first report that site-specific augmentation of the endogenous MBNL1 transcription mitigates disease-associated AltS defects and as such, it offers new perspectives into therapeutic options against DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myotonic DystrophyRNA-Binding ProteinsPromoter Regions, GeneticAlternative SplicingHumansTranscription, GeneticTranscriptional ActivationRNA Polymerase II

Substanzen

MBNL1 protein, humanRNA-Binding ProteinsRNA Polymerase II

Autor:innen und Institutionen

  • Laboratory of RNA Biology, Department of Biochemistry and Biotechnology, Poznan University of Life Sciences, Dojazd 11, 60-632 Poznan, Poland.
  • Doctoral School of Natural Sciences, Adam Mickiewicz University, Uniwersytetu Poznanskiego 2, 61-614 Poznan, Poland.
  • Poznan University of Life Sciences Doctoral School, Collegium Maximum, Wojska Polskiego 28, 60-637 Poznan, Poland.

ORCID-Profile: Nikola Musiała-Kierklo, Patrycja Plewka, Adam Jasiok, Ewa Stępniak-Konieczna

Förderung

  • National Science Centre

Zitieren

APA

Musiała-Kierklo, N., Plewka, P., Jasiok, A., & Stępniak-Konieczna, E. (2025). Promoter-targeted small RNA duplexes increase MBNL1 transcription and mitigate myotonic dystrophy-associated spliceopathy. Nucleic Acids Research, 53(15). https://doi.org/10.1093/nar/gkaf756

Vancouver

Musiała-Kierklo N, Plewka P, Jasiok A, Stępniak-Konieczna E. Promoter-targeted small RNA duplexes increase MBNL1 transcription and mitigate myotonic dystrophy-associated spliceopathy. Nucleic Acids Research. 2025;53(15). doi:10.1093/nar/gkaf756

BibTeX
@article{MusiaaKierklo2025,
  author = {Musiała-Kierklo, Nikola and Plewka, Patrycja and Jasiok, Adam and Stępniak-Konieczna, Ewa},
  title = {Promoter-targeted small RNA duplexes increase MBNL1 transcription and mitigate myotonic dystrophy-associated spliceopathy},
  journal = {Nucleic Acids Research},
  year = {2025},
  volume = {53},
  number = {15},
  doi = {10.1093/nar/gkaf756}
}
Kostenlos starten →